300601.SZ · 康泰生物
China A-shares · RS rating 75 · As of 2026-10-14
| Price | 12.69 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 79 / 78 / 32 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 17 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +1.7% |
| Distance from 52-week high | +27.5% |
| Market cap (USD) | $2.2B |